Evidence map›Paper›PMID 38030608›Full record

ArticleNature communications2023

TRS: a method for determining transcript termini from RNAtag-seq sequencing data.

Amir Bar, Liron Argaman, Michal Eldar, Hanah Margalit

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Analysis of 3'-seq data from multiplebioRxiv : the preprint server for biology · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amir BarDepartment of Microbiology and Molecular Genetics IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112102, Israel.
Liron ArgamanDepartment of Microbiology and Molecular Genetics IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112102, Israel.
Michal EldarDepartment of Microbiology and Molecular Genetics IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112102, Israel.
Hanah MargalitDepartment of Microbiology and Molecular Genetics IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112102, Israel. hanahm@ekmd.huji.ac.il.ORCID 0000-0002-2274-7784

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 833598Israel Science Foundation (ISF) 1253/22
6 · The paper itself

Abstract

In bacteria, determination of the 3' termini of transcripts plays an essential role in regulation of gene expression, affecting the functionality and stability of the transcript. Several experimental approaches were developed to identify the 3' termini of transcripts, however, these were applied only to a limited number of bacteria and growth conditions. Here we present a straightforward approach to identify 3' termini from widely available RNA-seq data without the need for additional experiments. Our approach relies on the observation that the RNAtag-seq sequencing protocol results in overabundance of reads mapped to transcript 3' termini. We present TRS (Termini by Read Starts), a computational pipeline exploiting this property to identify 3' termini in RNAtag-seq data, and show that the identified 3' termini are highly reliable. Since RNAtag-seq data are widely available for many bacteria and growth conditions, our approach paves the way for studying bacterial transcription termination in an unprecedented scope.

Indexed as

BacteriaTranscription, GeneticGene Expression ProfilingHigh-Throughput Nucleotide SequencingSequence Analysis, RNATranscriptome

Identifiers

PMID38030608
PMCPMC10687069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.